Replies to post #317902 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Wow. Great article. Seriously. Thanks alexander77.

https://www.heraldtribune.com/story/business/2020/10/14/deduced-reckoning-northwest-biotherapeutics-ready-prime-time/3656047001/

[Kaizenman]

Interesting article. No doubt this will draw new money into NWBO. Thanks for posting!

[TiltMyBrain]

Starting to get Wall Street coverage!!

[VuBru]

Nice article!

[xoma4578]

Alexander77 - appreciate you sharing this exciting article.

[CaptainObvious]

This is an amazing article.
I posted to Facebook. Lol

[limer814]

Excellent article..Prime Time..

[survivor1x]

All over Twitter. Someone send this to 60 minutes! Great find.

[CassieW]

This is EXACTLY the kind of respectable, level headed coverage we need!

ALL ABOARD!

$NWBO

[beartrap12]

Thanks, Alexander. We’re going to break out of the gates tomorrow!
BTW, where is the Herald Tribune located?

[HappyLibrarian]

Going to put some Grey Poupon on my Crow: It looks like one of Linda Powers conference presentations paid off after all and got us, with some delay, this coverage.

[abeta]

Since 2005, more than
400 GBM trials have failed,
some after promising Phase 2 studies.

Most stunning was the news that a single tumor could display more than 20,000 mutations of the original cancerous cells.

Alexander - Thank you for posting this article -
(I am quoting it above and below)


By Joan Lappin
Oct 14th 2020
Northwest Biotherapeutics is finally ready for prime time
https://www.heraldtribune.com/story/business/2020/10/14/deduced-reckoning-northwest-biotherapeutics-ready-prime-time/3656047001/

NWBO combines material from your own resected tumor with dendritic cells (withdrawn from your blood), which are then trained in the lab to recognize your tumor. Because the DCVAX-L that is ultimately returned to your body is your body’s own enhanced material it is not rejected as foreign. Therefore, there is no toxicity to this treatment.

I own it; Gramercy Capital and all of our clients own it. In recent weeks, NWBO has finally completed its Phase 3 trial. The data has been locked and sent off to the statisticians for evaluation.

Right now, NWBO is valued at less than $1 billion. If the trial is successful, and we will know quickly, this undervaluation will correct rapidly.
Immunomedics was recently acquired for $21 billion by Gilead with a less promising drug

regards

[Chiugray]

Nice find. Now I know who she is. Very positive news.

Joan Lappin, CFA, has enjoyed a long and storied Wall Street career. She has successfully managed portfolios for major American corporations and high-net-worth individuals since 1980. Her firm, Gramercy Capital Mgt. has been ranked #1 in the Nelson's Directory of Registered Investment Advisors. Her stock picking prowess is legendary. She's been on CNBC, Bloomberg, Fox, and PBS and wrote for Forbes for a decade. Read her unique insights into evolving investment trends Thursdays in the Sarasota Herald Tribune.

[kfa670]

FINALLY...

Someone outside The Matrix of Larry Smith, Bert and Ernie's Basement BS Show and random crap written pennystock pump articles... acknowledges the existence of this therapy and it's potential.

[eagle8]

Thanks for sharing alexander.


GLTU